Kirsten H Edmiston MD
Breast, Surgical Oncology (Other than Breast)
System, Chief Surgical Quality Officer
Join to View Full Profile
3580 Joseph Siewick Dr101Fairfax, VA 22033
Phone+1 571-472-1600
Fax+1 703-391-4159
Dr. Edmiston is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MarylandResidency, Surgery, 1988 - 1993
Lewis Katz School of Medicine at Temple UniversityClass of 1988
Certifications & Licensure
CA State Medical License 1993 - Present
VA State Medical License 1997 - 2026
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow American College of Surgeons
Clinical Trials
- New Individualized Therapy Trial for Metastatic Colorectal Cancer Start of enrollment: 2009 Jun 01
- Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial) Start of enrollment: 2009 Dec 01
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Start of enrollment: 2010 Mar 01
Publications & Presentations
PubMed
- ASO Visual Abstract: Changes in Surgical Management of the Axilla Over 11 Years-Report on Over 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the...Judy C Boughey, Hongmei Yu, Catherine Lu Dugan, Mara A Piltin, Lauren Postlewait
Annals of Surgical Oncology. 2023-10-01 - 20 citationsChanges in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I...Judy C Boughey, Hongmei Yu, Catherine Lu Dugan, Mara A Piltin, Lauren Postlewait
Annals of Surgical Oncology. 2023-10-01 - 58 citationsAssessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clini...W. Fraser Symmans, Christina Yau, Yunn Yi Chen, Ronald Balassanian, Molly Klein
JAMA Oncology. 2021-09-16
Press Mentions
New Quality Verification Program for Hospitals Will Benefit Participants in ACS NSQIPOctober 27th, 2021
George Mason University Breast Cancer Treatment Patent Licensed by Targeted PharmaceuticalsJuly 23rd, 2019
Virginia Hospital Uses Patients’ DNA to Customize TreatmentNovember 13th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
